AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹42 Cr | ₹41 Cr | ₹177 Cr | ₹285 Cr | ₹275 Cr |
What is the latest Total Non-Current Liabilities ratio of AJANTA PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹42 Cr |
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹177 Cr |
| Mar2022 | ₹285 Cr |
| Mar2021 | ₹275 Cr |
How is Total Non-Current Liabilities of AJANTA PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹42 Cr | 3.21 | |
| Mar2024 | ₹41 Cr | -76.99 | |
| Mar2023 | ₹177 Cr | -37.77 | |
| Mar2022 | ₹285 Cr | 3.81 | |
| Mar2021 | ₹275 Cr | - | |
Compare Total Non-Current Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹33,849.8 Cr | -3.3% | -7.1% | 4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -2.2% | -1.8% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,282.0 Cr | -1.6% | -7.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -4.1% | -6.7% | 23.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -4.7% | -7.3% | 6.4% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -1.7% | -8.4% | -16.7% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -3.3% |
-7.1% |
4.7% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses